UiPath, Inc. provides an automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. It offers the UiPath platform, an integrated enterprise software platform that enables AI agents, robots, people, and models to work together in coordinated workflows. The company's UiPath platform includes the UiPath Maestro process orchestration and process intelligence; UiPath agent builder; RPA and API automation; UiPath intelligent xtraction and processing; UiPath test cloud for testing and quality assurance; UiPath packaged and prebuilt agentic solutions; and centralized governance capabilities that apply across automations, AI agents, and manual tasks. It serves the financial services, healthcare, manufacturing, retail, and public sectors. The company was founded in 2005 and is headquartered in New York, New York.
Country
Sector
Themes
Also in
Price· split & dividend adjusted
No price history for this asset yet.
News & notes movingPATH
Artificial Intelligence▲
Banco Azteca Scales to 8,800 Orchestrated Processes with UiPath Maestro
UiPath announced that Banco Azteca, one of Mexico's largest financial institutions, has transformed its automation program using UiPath Maestro to orchestrate complex, end-to-end business processes across more than 8,800 enterprise processes and more than 300 automations. Since launching its automation journey in 2020 and establishing an internal AI and RPA Center of Excellence, the bank has built one of Latin America's most mature automation programs, led by over 20 developers, business analysts, and data scientists under the executive sponsorship of Manuel Delgado Forey, Chief Operating Officer and Head of Customer Service. The orchestrated workflows, which coordinate people, AI agents, systems, and third-party partners, have scaled to the equivalent of over 3,300 full-time employees, improving visibility, governance, and scalability. A flagship example is Elektra's post-sales operation for elektra.mx, which now processes cancellation, delivery, and order-related requests with reduced manual effort and significantly accelerated resolution times. Looking ahead, Banco Azteca plans to extend this model into anti-money laundering initiatives and intelligent ATM monitoring.
Leveraged ETFs on Microsoft, AXT, UiPath, and Amazon Surge After Earnings
Leveraged single-stock ETFs tied to Microsoft, AXT, UiPath, and Amazon posted sharp gains last week following strong earnings reports. The Direxion Daily MSFT Bull 2X ETF rose 38.9% as Microsoft shares jumped 19% after better-than-expected fiscal fourth-quarter 2026 results driven by Azure growth and AI demand. The Tradr 2X Long AXTI Daily ETF gained 35.4% as AXT shares surged 24.7% on a blowout second-quarter 2026 report with record indium phosphide revenues. The Tradr 2X Long PATH Daily ETF advanced 32.6% as UiPath shares climbed 14.2% on strong enterprise demand for AI-driven automation. The GraniteShares 2x Long AMZN Daily ETF added 31.0% as Amazon shares rose 15.3% after an AWS-fueled earnings beat that sent the stock up 10% immediately, with AWS revenue jumping 37% and its AI business and chips each generating over $25 billion in annualized revenue.
Tetragon Financial Group Reports Negative 2.5% NAV Return for First Half of 2026
Tetragon Financial Group Ltd reported a negative net asset value per share total return of 2.5% for the first half of 2026. Fully diluted NAV per share fell to $46.00 at June 30, 2026, down from $41.88 at the end of 2025. The company declared a dividend of $0.12 per share for the second quarter, unchanged from the first quarter, representing an annualized yield of approximately 3.6%. Aggregate investment performance was a net loss of $131.4 million, driven by a $138.9 million loss in private equity and venture capital, mainly from a decline in Ripple's share price from $150 to $109, and a $69.2 million loss in other equities due to mark-to-market losses in UiPath. These were partially offset by a $120.2 million gain in Tetragon Partners, driven by BGO and Equitix investments. The company's net cash position was negative $135.8 million at the end of June, with $185 million drawn on its revolving credit facility.
U.S. Robotics Stocks Gain as Physical AI, Surgical Competition, and Defense Autonomy Accelerate
The American robotics industry has entered a decisive acceleration phase in 2026, with June and July emerging as a landmark period across physical AI, surgical systems, defense autonomy, and elder care. In June, BMW Group announced plans to deploy Figure AI's third-generation Figure 03 humanoid at its Spartanburg plant, while NEURA Robotics closed a Series C worth up to $1.4 billion, and humanoid startups have raised $8.6 billion in 2026, 1.8 times the full-year 2025 total. On July 22, the FDA granted de novo authorization to Johnson & Johnson's Ottava system for ten general surgery procedures, breaking a long era of single-platform dominance, and Medtronic unveiled its AI-native Touch Surgery Aide platform. Defense robotics drew fresh capital with Mach Industries raising $300 million and Shifters securing $10.2 million, while the global elder care assistive robot market is projected at $3.9 billion in 2026, reaching $9.8 billion by 2033. Synopsys raised its fiscal 2026 revenue guidance to $9.665 billion at midpoint, AMD unveiled its Ryzen AI Embedded X100 Series for robotics, Manhattan Associates reaffirmed full-year guidance of $1.15 billion in revenues, and UiPath targets fiscal 2027 ARR of approximately $2.06 billion.
Marvell Technology posts steady quarterly revenue growth while UiPath fluctuates
Marvell Technology and UiPath both reported year-over-year revenue increases in their latest quarters, but their quarterly trends diverged. Marvell Technology, which joined the S&P 500 on June 22, 2026, grew revenue sequentially from $2.2 billion in the quarter ended January 2026 to $2.4 billion in the quarter ended May 2026, and it forecasts about $2.7 billion next quarter. UiPath saw revenue rise 17% year over year to $418.4 million in the quarter ended April 2026, though that was down from $481.1 million in the prior quarter, and it guided for $395 million to $400 million next quarter. Over the past 12 months through July 24, Marvell’s stock surged over 150% while UiPath’s fell more than 10%.
UiPath Stock Falls 15% After OpenAI Launch, But Sell-Off May Be Overdone
UiPath shares dropped nearly 15% from their recent peak by midday Thursday, triggered by OpenAI's launch of a new offering called OpenAI Presence. The solution helps organizations deploy AI agents for customer service, sales, HR, and IT support, but it focuses on probabilistic tasks, while UiPath's software bots handle deterministic, rules-based work like data entry and payroll where accuracy is critical. UiPath's own agentic AI platform, Maestro, can route tasks to either AI agents or cheaper software bots and is model-agnostic, reducing reliance on any single AI vendor. With the stock trading at a forward P/E of about 13.5 and a price-to-sales ratio just above 3, the pullback appears overdone, and UiPath could play an important role in enterprise AI agent orchestration.
UiPath Gains on Retail AI Partnership with The Very Group
UiPath closed at $12.15, up 1.00%, following a retail artificial intelligence partnership with UK online retailer The Very Group. The enterprise automation and robotic software provider will supply agentic AI pricing solutions under the deal. Trading volume reached 90.6 million shares, about 86% above its three-month average of 48.7 million shares. The stock has fallen 81% since its 2021 IPO and remains down over 26% year-to-date despite the day's gains.
UiPath vs. ServiceNow: Which Agentic AI Stock Is the Better Buy?
ServiceNow and UiPath are both positioned to benefit from the enterprise agentic AI market, which Grand View Research forecasts will grow at a 46.2% compound annual rate through 2030. ServiceNow has higher annual recurring revenue growth, with subscription revenue up 22% year-over-year in its latest quarter, compared to UiPath's 12% subscription growth and 17% overall revenue increase. ServiceNow also has 630 customers spending more than $5 million annually, while UiPath has 374 customers spending over $1 million. However, UiPath recently achieved GAAP profitability in a fiscal first quarter for the first time, and its net profit margin of just above 5% has more room to expand toward ServiceNow's double-digit margins, potentially improving its valuation. Both companies trade at similar price-to-earnings ratios, but UiPath may offer better value for long-term investors focused on margin expansion.
UiPath Could Be 10% Undervalued After The Very Group Contract
UiPath stock is in focus after the company signed a three-year contract to build an AI-driven pricing platform for UK online retailer The Very Group. The stock last closed at $11.95, and a popular narrative fair value estimate of $13.31 suggests it could be about 10.2% undervalued. Recent momentum includes a 30-day share price return of 10.75%, though the five-year total shareholder return has declined roughly 81%. The company is emphasizing its agentic automation roadmap and go-to-market changes to deepen customer relationships and boost annual recurring revenue growth, while facing pressure points such as softer net new ARR, foreign exchange headwinds, and execution risks tied to a shift toward more SaaS-style contracts.
UiPath Reports First GAAP Operating Profit and AI Retail Win
UiPath reported its first-ever quarterly GAAP operating profit and announced a three-year agreement to build an AI-driven pricing platform for UK online retailer The Very Group. The company also highlighted that its AI agentic products are progressing from pilot to production, while maintaining a share repurchase program with about US$414 million still available. The Very Group deal underscores how UiPath's automation and AI tools are being applied to complex, margin-sensitive retail decisions, moving beyond small pilots into scaled production. The first GAAP operating profit supports the investment thesis of a durable, subscription-heavy software franchise with improving profitability, though softer near-term ARR guidance keeps execution risk in focus.
UiPath Stock Appears Undervalued by 40.6% on Cash Flow Basis After AI Contract Win
UiPath shares are trading near US$11.95, and a Discounted Cash Flow analysis suggests the stock may be undervalued by about 40.6% relative to an estimated intrinsic value of US$20.12 per share. The company generated approximately US$368.4 million in free cash flow over the last twelve months, and the valuation assumes continued cash flow growth, supported in part by a recent AI-driven automation contract with The Very Group. On an earnings basis, UiPath trades at about 18.9 times earnings, well below the broader Software industry average of 28.8 times and a peer group average near 40.4 times, while a tailored fair P/E ratio factoring in its growth profile and margins is estimated at roughly 24.8 times. Despite these valuation signals, the stock has declined around 81.0% over the past five years, and ongoing concerns about execution quality and competitive pressure in automation and AI remain key risks that could explain the market's cautious pricing.
Zebra Technologies and UiPath both trade at 15 times forward earnings as automation demand rises
Zebra Technologies and UiPath are both trading at around 15 times forward earnings, with Zebra's stock up more than 11% this year. Zebra reported first-quarter sales of $1.49 billion, up 14.3% year over year, and lifted its full-year 2026 outlook to sales growth of 10% to 14% and non-GAAP EPS between $18.30 and $18.70. UiPath posted revenue of $418.4 million in its fiscal 2027 first quarter, up 17.3% year over year, and achieved its third consecutive quarter of GAAP profitability with EPS of $0.04. Both companies are benefiting from strong industrial automation trends, with a RobCo survey finding that 95% of U.S. industrial firms plan to introduce new automation over the next three years.
IonQ, SoundHound AI, and UiPath touted as better moonshot bets than SpaceX
The Motley Fool highlights IonQ, SoundHound AI, and UiPath as three speculative growth stocks that may be better moonshot investments than SpaceX. IonQ leads in quantum computing accuracy with trapped-ion qubits achieving 99.99% two-qubit gate fidelity, though it remains far from fault-tolerant operation, and it is acquiring SkyWater for a dedicated foundry. SoundHound AI, whose shares have fallen about 30% this year, is pursuing the customer service market through its pending acquisition of LivePerson, which would add a large customer base to its voice AI platform following its earlier Amelia deal. UiPath trades at a forward price-to-sales ratio of 3.5 and a forward price-to-earnings ratio of 15, and it aims to become an agentic AI orchestration leader by leveraging its robotic process automation foundation and Maestro platform, with revenue up 17% last quarter.
StockStory Highlights Vertiv as Cash-Rich Buy, Flags UiPath and Surgery Partners as Risky
StockStory identifies Vertiv as a cash-producing stock worth buying, while labeling UiPath and Surgery Partners as risky investments. Vertiv, formerly part of Emerson Electric, boasts a trailing 12-month free cash flow margin of 21.2%, average organic revenue growth of 23.7% over two years, and a free cash flow margin that increased by 22.4 percentage points over five years. In contrast, UiPath's annual revenue growth of 11.2% over two years and estimated sales growth of 8.2% for the next 12 months raise concerns, while Surgery Partners faces estimated sales growth of just 3.2% and a high net-debt-to-EBITDA ratio of 7×. Vertiv trades at $301.70 per share, UiPath at $11.70, and Surgery Partners at $16.89.
UiPath Gains as Agentic Automation Strategy Faces Earnings Test
UiPath closed at $11.69, up 1.21%, as investors focus on its agentic automation strategy ahead of the next earnings report. The company is moving beyond traditional robotic process automation to position itself as an orchestration layer for complex enterprise workflows, with the launch of Maestro Case supporting this shift. The upcoming earnings update is expected to provide clarity on whether the strategy is driving durable growth and higher enterprise demand. Meanwhile, the S&P 500 was unchanged at 7,483.24, and the Nasdaq Composite fell 0.80% to 25,832.
UiPath Launches Maestro Case to Tackle Complex Enterprise Workflows
UiPath has introduced Maestro Case, a new capability aimed at helping enterprises manage complex, non-linear workflows that involve people, systems, and AI. The tool treats each case as an evolving workflow, carrying data and context across stages while blending automation with human oversight, targeting fragmented processes often handled through emails and spreadsheets. The move positions UiPath more directly against ServiceNow and Pegasystems in workflow orchestration and case management, with its AI-led approach potentially offering differentiation. UiPath stock has fallen 39% year to date, and it trades at a forward price-to-earnings ratio of 11.91, below the industry average of 24.48, while the Zacks Consensus Estimate for fiscal 2027 earnings has risen over the past 30 days.
Automation software stocks fall 19.1% on average after Q1 earnings despite revenue beats
Automation software stocks tracked by this publication fell an average of 19.1% since their latest earnings results, even as the group's revenues beat analysts' consensus estimates by 1.5% and next-quarter revenue guidance was in line. UiPath reported revenues of $418.4 million, up 17.3% year on year and exceeding expectations by 5.2%, but its full-year revenue guidance only slightly topped estimates and it significantly missed billings estimates, sending its stock down 14%. SoundHound AI posted the fastest revenue growth among peers at 51.7% year on year to $44.2 million, beating estimates by 3.4%, yet its stock dropped 35.6%. Pegasystems recorded the weakest performance with revenues of $430 million, down 9.6% year on year and missing estimates by 7.3%, leading to a 25.8% stock decline. ServiceNow's revenues rose 22.1% year on year to $3.77 billion, beating estimates by 0.6%, but its stock fell 12.8%. Microsoft's revenues grew 18.3% year on year to $82.89 billion, topping estimates by 1.7%, and its stock declined 16.3%.
UiPath vs. Nu Holdings: Which Disruptive Growth Stock is a Buy?
UiPath appears to be a buy right now, while Nu Holdings faces near-term uncertainty from Brazil's high interest rates. UiPath is evolving into an enterprise AI orchestration platform, with AI product adoption driving higher customer spending and deeper enterprise relationships. The Zacks Consensus Estimate for UiPath's second-quarter fiscal 2027 earnings is 15 cents per share, flat year-over-year, on revenues of $397.6 million, up 9.9%. For full fiscal 2027, earnings are projected to increase 11.1%, followed by 12.7% growth in fiscal 2028, with revenues rising 10.4% and 8.2% respectively. Nu Holdings trades at roughly 12.63 times forward earnings, with expected revenue growth of 39% and EPS growth of 34% this year, and generates a 13.4% return on invested capital and a 30.9% return on equity. However, Brazil's central bank aggressively raised benchmark interest rates from 10.5% in June 2024 to 14.25% in June this year, then only slightly reduced them to 14.5%, heightening fears of an economic slowdown and consumer financial stress that could pressure Nu's loan book. UiPath carries a Zacks Rank #2 (Buy) and Nu carries a Zacks Rank #3 (Hold).
StockStory identifies Adobe, UiPath, and United Parks & Resorts as value stocks with structural challenges that investors should steer clear of. Adobe, trading at $195.58 per share with a forward price-to-sales ratio of 2.9x, showed sluggish demand with projected sales growth of 9.9% and flat operating margins. UiPath, priced at $10.32 and a 3x forward price-to-sales ratio, faces weak billings growth of 9.3% and estimated sales growth of 8.2%, signaling a slowdown. United Parks & Resorts, at $46.89 and a 10.6x forward price-to-earnings ratio, struggles with declining visitors, a low free cash flow margin of 12.1%, and waning returns on capital.
UiPath Stock Draws Heavy Investor Attention Amid Strong Earnings Estimate Revisions
UiPath has become one of the most searched stocks on Zacks.com, prompting a review of factors that could influence its near-term performance. Over the past month, shares of the enterprise automation software developer have returned negative 7%, while the Zacks Internet - Software industry lost 4.7% and the S&P 500 gained 0.1%. The Zacks Consensus Estimate for current-quarter earnings stands at $0.15 per share, unchanged from a year ago, but has surged 74.2% over the last 30 days. For the current fiscal year, the consensus estimate of $0.79 per share reflects a 9.7% increase from the prior year and has risen 18.4% in the past month, while the next fiscal year's estimate of $0.90 per share indicates 14.3% growth and has been revised 3.8% higher. These positive revisions have earned UiPath a Zacks Rank #2, or Buy, suggesting it may outperform the broader market in the near term.
UiPath Falls as Agentic Automation Push Faces ARR Growth Test
UiPath shares declined 1.07% to close at $10.15 despite the launch of Maestro Case, an AI-native tool for coordinating agents, robots, and people in complex enterprise workflows. Trading volume reached 51.8 million shares, about 47% above the three-month average of 33.6 million. The broader market also fell, with the S&P 500 down 0.37% and the Nasdaq Composite dropping 1.32%. Peer Pegasystems closed 2.36% lower at $29.38, highlighting continued pressure on automation names. Investors remain focused on whether UiPath's agentic automation push will translate into stronger annual recurring revenue growth, retention, and customer expansion in upcoming earnings.